Inflammation and acute cardiotoxicity in adult hematological patients treated with CAR-T cells: results from a pilot proof-of-concept study.
Massimiliano CamilliMarcello ViscovoTamara FeliciLuca MaggioFederico BallacciGiacomo CarellaAlice BonanniPriscilla LamendolaLorenzo TintiAntonio Di RenzoGiulia CoarelliEugenio GalliGiovanna LiuzzoFrancesco BurzottaRocco Antonio MontoneFederica SoràSimona SicaStefan HohausGaetano Antonio LanzaFilippo CreaAntonella LombardoGiorgio MinottiPublished in: Cardio-oncology (London, England) (2024)
There is a high incidence of early CTRCD in patients treated with CAR-T cells, and a link between CTRCD and inflammation can be demonstrated. Dedicated patient monitoring protocols are advised.